AUG 17, 2016 4:44 PM PDT

Patients bring superbugs to the hospital

WRITTEN BY: Kerry Evans
It is estimated that, in Germany, 15,000 people die from hospital-acquired “superbug” infections each year. A new study by University of Cologne researchers reveals that, often, patients bring these superbugs into the hospital from their own homes.

The researchers were particularly interested in one group of superbugs - the 3GCREBs (third-generation cephalosporin-resistant Enterobacteriaceae).
Patients bring superbugs into the hospital.
Cephalosporins are some of the most widely-used antibiotics these days. They work by inhibiting bacterial cell wall synthesis. Bacteria are fighting back, however. Enzymes called beta-lactamases degrade cephalosporins, making them harmless to the bacteria.

The group surveyed over 4,000 adults who were being admitted at 6 German University Hospitals. They tested each patient for multidrug resistant Enterobacteriaceae (stool samples or rectal swabs). These bacteria are harmless if they remain in your gut - where they normally live. When passed from one person to the other by “smear infection”, they can cause urinary tract infections, for example.

According to study author Axel Hamprecht, “we were surprised that on hospital admission almost every tenth patient is colonised with multidrug-resistant pathogens”. To be precise, 416 of 4,376 adults, or 9.5%, were 3GCREB carriers. E. coli was the most common species found, with an incidence of 79.1%. A smaller number of patients, 0.11%, were carriers of carbapenemase-producing Enterobacteriaceae. Carbapenemases are a type of beta-lactamase that can degrade a number of antibiotics, including penicillins, cephalosporins, and carbapenems.

They also identified a handful of factors that make it more likely for you to be a superbug-carrier. These include antibiotic use within the last 6 months, treatment for gastroesophageal reflux disease, residing in a longterm care facility, and traveling outside of Europe (remember, this study was conducted in Germany).

Another important point is that these superbug-carriers were not ICU patients. That is, you don’t have to be severely ill to risk contracting or spreading a superbug infection.

According to Hamprecht, 3GCREBs may be the next superbugs to worry about. “With so many people affected, the strategy of isolating patients within the hospitals no longer works. Additionally, in contrast to other groups of multidrug-resistant bacteria such as MRSA (Methicillin-resistant Staphylococcus aureus) strains, standardised sanitation measures for 3GCREB have not been established.”
 


Sources: Journal of Antimicrobial Chemotherapy, MedicalXpress
 
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
NOV 26, 2019
Microbiology
NOV 26, 2019
New Drug Can Promote Resistance in the Flu Virus
A flu drug, while still safe and effective, encourages flu viruses to mutate, especially in children....
DEC 22, 2019
Microbiology
DEC 22, 2019
Viruses Can Escape the Effects of CRISPR by Shielding Their Genomes
Our world is filled with microbes, and in every kind of environment, they compete for supremacy, a competition that dates back to the origins of life....
JAN 11, 2020
Cell & Molecular Biology
JAN 11, 2020
To Save Others, Bacteria Can Self-Destruct When Infected by a Virus
Scientists were studying viruses that infect and kill bacteria as a medicine for bacterial infections over a hundred years ago, and they are a focus of recent research as well....
JAN 15, 2020
Microbiology
JAN 15, 2020
Scientists Engineer a New Kind of Life Form
Usig cells harvested from frogs, researchers created tiny robots....
JAN 22, 2020
Microbiology
JAN 22, 2020
Tuberculosis Pathogen Can Survive in Soil Amoebae
Researchers have learned that the bacterium that causes bovine tuberculosis is able to survive and grow inside of amoeba that live in soil....
FEB 17, 2020
Immunology
FEB 17, 2020
Another HIV vaccine attempt fizzles out
Years of work and over $100 million in study costs have been abandoned after an HIV-vaccine tested in South Africa failed to protect treated individuals ag...
Loading Comments...